Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2491-2497

  Cortes, Jorge ^a   Fayad, Luis ^a   O'Brien, Susan ^a   Keating, Michael ^a   Kantarjian, Hagop ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FOLINATE CALCIUM; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DRUG MEGADOSE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA CELL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REMISSION INDUCTION; TIME FACTORS; VINCRISTINE;

EID: 0032882041     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kantarjian, H. M., Walters, R. S., Keating, M. J., Smith, T. L., O'Brien, S., Estey, E. H., Huh, Y.O., Spinolo, J., Dicke, K., and Barlogie, B. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. Journal of Clinical Oncology, 8: 994-1004, 1990.
2. Geissler, K., Koller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knobl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U., Heinz, R., Linkesch, W., and Lechner, K. Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - a randomized phase-III study. Blood, 90: 590-596, 1997.
3. Larson, R. A., Dodge, R. K., Linker, C. A., Stone, R. M., Powell, B. L., Lee, E. J., Schulman, P., Davey, F. R., Frankel, S. R., Bloomfield, C. D., George, S. L., and Schiffer, C. A. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood, 92: 1556-1564, 1998.
4. Linker, C. A., Levitt, L. J., O'Donnell, M., Forman, S. J., and Ries, C. A. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood, 78: 2814-2822, 1991.
5. Cortes, J. E., and Kantarjian, H. M. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer (Phila.), 76: 2393-2417, 1995.
6. Hoelzer, D. F. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol-Oncol. Clin. N. Am., 7: 139-160, 1993.
7. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., and Ruhl, H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71: 123-131, 1988.
8. Frei, E., and Sallan, S. E. Acute lymphoblastic leukemia: treatment. Cancer (Phila.), 42: 828-838, 1978.
9. Steinherz, P. G., Gaynon, P. S., Breneman, J. C., Cherlow, J. M., Grossman, N. J., Kersey, J. H., Johnstone, H. S., Sather, H. N., Trigg, M. E., Chappell, R., Hammond, D., and Bleyer, W. A. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Childrens Cancer Group. J. Clin. Oncol., 14: 389-398, 1996.
10. Gaynon, P. S., Bleyer, W. A., Steinherz, P. G., Finklestein, J. Z., Littman, P., Miller, D. R., Reaman, G., Sather, H., and Hammond, G. D. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med. Pediatr. Oncol., 18: 273-279, 1990.
11. Rivera, G. K., Raimondi, S. C., Hancock, M. L., Behm, F. G., Pui, C. H., Abromowitch, M., Mirro, J., Jr., Ochs, J. S., Look, A. T., and Williams, D. L. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet, 337: 61-66, 1991.
12. Gajjar, A., Ribeiro, R., Hancock, M. L., Rivera, G. K., Mahmoud, H., Sandlund, J. T., Crist, W. M., and Pui, C. H. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood, 86: 1292-1295, 1995.
13. Rautonen, J., Hovi, L., and Siimes, M. A. Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood, 71: 989-991, 1988.
14. Coustan-Smith, E., Behm, F. G., Sanchez, J., Boyett, J. M., Hancock, M. L., Raimondi, S. C., Rubnitz, J. E., Rivera, G. K., Sandlund, J. T., Pui, C. H., and Campana, D. Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet, 351: 550-554, 1998.
15. van Dongen, J. J. M., Seriu, T., Panzer-Grumayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., Gadner, H., van Wering, E. R., Ludwig, W. D., Basso, G., de Bruijn, M. A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W. C., Riehm, H., and Bartram, C. R. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood. Lancet, 352: 1731-1738, 1998.
16. Cave, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B., and Vilmer, E. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. N. Engl. J. Med., 339: 591-598, 1998.
17. Dibenedetto, S. P., Lo Nigro, L., Mayer, S. P., Rovera, G., and Schiliro, G. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia. Blood, 90: 1226-1232, 1997.
18. Brisco, M. J., Condon, J., Hughes, E., Neoh, S. H., Sykes, P. J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., and Ekert, H. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction [see comments]. Lancet, 343: 196-200, 1994.
19. Wasserman, R., Galili, N., Ito, Y., Silber, J. H., Reichard, B. A., Shane, S., Womer, R. B., Lange, B., and Rovera, G. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J. Clin. Oncol., 10: 1879-1888, 1992.
20. Altman, D. G. Practical Statistics for Medical Research, Ed. 1. London: Chapman & Hall, 1991.
21. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 157-160, 1958.
22. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
23. Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., and Gee, T. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J. Clin. Oncol., 6: 1014-1030, 1988.
24. Jacquillat, C., Weil, M., Gemon, M. F., Auclerc, G., Loisel, J. P., Delobel, J., Flandrin, G., Schaison, G., Izrael, V., Bussel, A., Dresch, C., Weisgerber, C., Rain, D., Tanzer, J., Najean, Y., Seligmann, M., Boiron, M., and Bernard, J. Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris). Cancer Res., 33: 3278-3284, 1973.
25. Miller, D. R., Leikin, S., Albo, V., Sather, H., Karon, M., and Hammond, D. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group. Cancer (Phila.), 57: 1041-1049, 1983.
26. Miller, D. R., Coccia, P. F., Bleyer, W. A., Lukens, J. N., Siegel, S. E., Sather, H. N., and Hammond, G. D. Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J. Clin. Oncol., 7: 1807-1815, 1989.
27. Keating M. J., Smith T. L., Gehan E. A., McCredie, K. B., Bodey, G. P., Spitzer, G., Hersh, E., Gutterman, J., and Freireich, E. J. Factors related to length of complete remission in adult acute leukemia. Cancer (Phila.), 45: 2017-2029, 1980.
28. Sebban, C., Browman, G. P., Lepage, E., and Fiere, D. Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials. Leuk, Res., 19: 861-868, 1995.
29. Poplack, D. G., and Reaman, G. Acute lymphoblastic leukemia in childhood. Pediatr. Clin. N. Am., 35: 903-932, 1988.
30. Fenaux, P., Lai, J. L., Miaux, O., Zandecki, M., Jouet, J. P., and Bauters, F. Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases [see comments]. Br. J. Haematol., 71: 371-376, 1989.
31. Hoelzer, D., Ludwig, W .D., Thiel, E., Gassmann, W., Loffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Buchner, T., Koch, P., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T. H., Gramatzki, M., Diedrich, H., Kolbe, K., and Uberla, K. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood, 87: 495-508, 1996.
32. Magrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N., Gootenberg, J., Neely, J., Arndt, C., Nieder, M., Jaffe, E., Wittes, R. A., and Horak, I. D. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J. Clin. Oncol., 14: 925-934, 1996.